Suppression of pulmonary granulomatous inflammation by immunomodulating agents-Reference-Cited by-同舟云学术

Suppression of pulmonary granulomatous inflammation by immunomodulating agents

Published:1992-09 Issue:1-2 Volume:37 Page:99-106
ISSN:0065-4299
Container-title:Agents and Actions
language:en
Short-container-title:Agents and Actions

Author:

Hashimoto M.,Kobayashi K.,Yamagata N.,Katsura T.,Sugihara S.,Iwabuchi H.,Kasama T.,Kasahara K.,Takahashi T.,Takeshita K.,Otomo S.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Toxicology,Pharmacology,Immunology

Link

http://link.springer.com/content/pdf/10.1007/BF01987896.pdf

Reference31 articles.

1. D. O. Adams,The granulomatous inflammatory response. Am. J. Pathol.84, 164–191 (1976).

2. D. L. Boros,Granulomatous inflammation. Prog. Allergy24, 184–243 (1978).

3. S. L. Kunkel, S. W. Chensue, R. M. Strieter, J. P. Lynch and D. G. Remick,Cellular and molecular aspects of granulomatous inflammation. Am. J. Respir. Cell Mol. Biol.1, 439–448 (1989).

4. K. Kobayashi, C. Allred, S. Cohen and T. Yoshida,Role of interleukin-1 in experimental pulmonary granuloma in mice. J. Immunol.134, 358–364 (1985).

5. C. Allred, K. Kobayashi and T. Yoshida,Anergy-like immunosuppression in mice bearing pulmonary foreign-body granulomatous inflammation. Am. J. Pathol.121, 466–473 (1985).

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Merger of Visible Light‐Driven Chiral Organocatalysis and Continuous Flow Chemistry: An Accelerated and Scalable Access into Enantioselective α‐Alkylation of Aldehydes;Advanced Synthesis & Catalysis;2023-05-16

2. An Unusual and Fatal Cause of Miliary Nodules on Chest Radiography;Journal of Clinical Medicine;2018-06-29

3. Synthesis and structure–activity relationships of 5-phenylthiophenecarboxylic acid derivatives as antirheumatic agents;Bioorganic & Medicinal Chemistry;2003-11

4. Synthesis and Antirheumatic Activity of the Metabolites of Esonarimod;Bioorganic & Medicinal Chemistry;2002-08

5. Effects of a new anti-rheumatic drug KE-298 and its active metabolite: KE-758 on secretion of thioredoxin and on the level of intracellular glutathione in human monocytes and T cells;Molecular Immunology;2002-02